Estrogen-Related Receptor α (ERRα) and G Protein-Coupled Estrogen Receptor (GPER) Synergistically Indicate Poor Prognosis in Patients with Triple-Negative Breast Cancer
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Estrogen-Related Receptor α (ERRα) and G Protein-Coupled Estrogen Receptor (GPER) Synergistically Indicate Poor Prognosis in Patients with Triple-Negative Breast Cancer
Authors
Keywords
-
Journal
OncoTargets and Therapy
Volume Volume 13, Issue -, Pages 8887-8899
Publisher
Informa UK Limited
Online
2020-09-07
DOI
10.2147/ott.s265372
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- AJCC 8th edition prognostic staging provides no better discriminatory ability in prognosis than anatomical staging in triple negative breast cancer
- (2020) Jiehua He et al. BMC CANCER
- Estradiol induces BDNF/TrkB signaling in triple-negative breast cancer to promote brain metastases
- (2019) Maria J. Contreras-Zárate et al. ONCOGENE
- Prognostic role of GPER/Ezrin in triple-negative breast cancer is associated with menopausal status
- (2019) Shuang Ye et al. Endocrine Connections
- Triple negative breast cancer: new therapeutic approaches and BRCA status
- (2018) Gamze Guney Eskiler et al. APMIS
- Update on the Treatment of Early-Stage Triple-Negative Breast Cancer
- (2018) Priyanka Sharma CURRENT TREATMENT OPTIONS IN ONCOLOGY
- Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Focused Update
- (2018) Antonio C. Wolff et al. JOURNAL OF CLINICAL ONCOLOGY
- Pharmacological activation of estrogen receptor beta augments innate immunity to suppress cancer metastasis
- (2018) Linjie Zhao et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Insights into the role of estrogen-related receptors α, β and γ in tumor Leydig cells
- (2018) Malgorzata Kotula-Balak et al. TISSUE & CELL
- Signaling Pathways Regulating Redox Balance in Cancer Metabolism
- (2018) Maria Chiara De Santis et al. Frontiers in Oncology
- ERβ-mediated induction of cystatins results in suppression of TGFβ signaling and inhibition of triple-negative breast cancer metastasis
- (2018) Jordan M. Reese et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Triple-Negative Breast Cancer: Current State of the Art
- (2018) Francesca Rastelli et al. TUMORI
- Estrogen receptor-α36 is involved in icaritin induced growth inhibition of triple-negative breast cancer cells
- (2017) Xue Wang et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Probing the metabolic phenotype of breast cancer cells by multiple tracer stable isotope resolved metabolomics
- (2017) Andrew N. Lane et al. METABOLIC ENGINEERING
- The presence and impact of estrogen metabolism on the biology of triple-negative breast cancer
- (2016) Keely May McNamara et al. BREAST CANCER RESEARCH AND TREATMENT
- Triple-negative breast cancer has worse overall survival and cause-specific survival than non-triple-negative breast cancer
- (2016) Xiaoxian Li et al. BREAST CANCER RESEARCH AND TREATMENT
- Targeting Estrogen Receptor Beta in a Phase 2 Study of High-Dose Estradiol in Metastatic Triple-Negative Breast Cancer: A Wisconsin Oncology Network Study
- (2016) Kari B. Wisinski et al. Clinical Breast Cancer
- There and back again: The journey of the estrogen-related receptors in the cancer realm
- (2016) Ingrid S. Tam et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Research progress on the reproductive and non-reproductive endocrine tumors by estrogen-related receptors
- (2016) Zhixiang Xu et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- 17β-estradiol-induced growth of triple-negative breast cancer cells is prevented by the reduction of GPER expression after treatment with gefitinib
- (2016) Rainer Girgert et al. ONCOLOGY REPORTS
- Estrogen stimulated migration and invasion of estrogen receptor-negative breast cancer cells involves an ezrin-dependent crosstalk between G protein-coupled receptor 30 and estrogen receptor beta signaling
- (2016) Kewen Zhou et al. STEROIDS
- The PGC-1α/ERRα Axis Represses One-Carbon Metabolism and Promotes Sensitivity to Anti-folate Therapy in Breast Cancer
- (2016) Étienne Audet-Walsh et al. Cell Reports
- Estrogen regulates Hippo signaling via GPER in breast cancer
- (2015) Xin Zhou et al. JOURNAL OF CLINICAL INVESTIGATION
- The G-protein coupled estrogen receptor, GPER: The inside and inside-out story
- (2015) H.M. Gaudet et al. MOLECULAR AND CELLULAR ENDOCRINOLOGY
- GPER mediates enhanced cell viability and motility via non-genomic signaling induced by 17β-estradiol in triple-negative breast cancer cells
- (2014) Tenghua Yu et al. JOURNAL OF STEROID BIOCHEMISTRY AND MOLECULAR BIOLOGY
- Biology of the estrogen receptor, GPR30, in triple negative breast cancer
- (2013) Jennifer Steiman et al. AMERICAN JOURNAL OF SURGERY
- G protein-coupled estrogen receptor (GPER) expression in endometrial adenocarcinoma and effect of agonist G-1 on growth of endometrial adenocarcinoma cell lines
- (2013) Maciej Skrzypczak et al. STEROIDS
- Triple-negative breast cancer in the older population
- (2012) M. Aapro et al. ANNALS OF ONCOLOGY
- Survival and clinicopathological characteristics of breast cancer patient according to different tumour subtypes as determined by hormone receptor and Her2 immunohistochemistry. A single institution survey spanning 1998 to 2010
- (2012) A. García Fernández et al. BREAST
- Metabolic Reprogramming: A Cancer Hallmark Even Warburg Did Not Anticipate
- (2012) Patrick S. Ward et al. CANCER CELL
- The Metabolic Regulator ERRα, a Downstream Target of HER2/IGF-1R, as a Therapeutic Target in Breast Cancer
- (2011) Ching-yi Chang et al. CANCER CELL
- G-protein Coupled Estrogen Receptor 1 Expression in Primary Breast Cancers and Its Correlation with Clinicopathological Variables
- (2011) Hao-jun Luo et al. Journal of Breast Cancer
- American Society of Clinical Oncology/College of American Pathologists Guideline Recommendations for Immunohistochemical Testing of Estrogen and Progesterone Receptors in Breast Cancer
- (2010) M. Elizabeth H. Hammond et al. JOURNAL OF CLINICAL ONCOLOGY
- Regulation of ERRα Gene Expression by Estrogen Receptor Agonists and Antagonists in SKBR3 Breast Cancer Cells: Differential Molecular Mechanisms Mediated by G Protein-Coupled Receptor GPR30/GPER-1
- (2010) Yin Li et al. MOLECULAR ENDOCRINOLOGY
- Triple-negative breast cancer--current status and future directions
- (2009) O. Gluz et al. ANNALS OF ONCOLOGY
- Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
- (2009) M. G. Vander Heiden et al. SCIENCE
- Sites of distant recurrence and clinical outcomes in patients with metastatic triple-negative breast cancer
- (2008) Nancy U. Lin et al. CANCER
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More